CMMB Chemomab Therapeutics Ltd.: institutional ownership and insider trading
13 funds reported holding $619K of Chemomab Therapeutics Ltd. in their latest 13F filings; in Q2 2026 funds net bought $45.8K, with 1 new positions and 3 funds selling out; over the last 12 months insiders bought $20.2K and sold $6.52K on the open market.
Famous investors holding CMMB
- Ken Griffin (Citadel Advisors): $154K, 0.0% of the portfolio
Largest institutional holders of CMMB
- CITADEL ADVISORS LLC — $154K
- ADAR1 Capital Management, LLC — $130K
- KESTRA PRIVATE WEALTH SERVICES, LLC — $100.0K
- Ikarian Capital, LLC — $83.9K
- RHUMBLINE ADVISERS — $49.5K
- XTX Topco Ltd — $25.9K
- Philadelphia Investment Partners, LLC — $24.3K
- Lido Advisors, LLC — $23.2K
- BNP PARIBAS FINANCIAL MARKETS — $11.0K
- GAMMA Investing LLC — $10.9K
Recent CMMB insider trades
- Aug 28, 2026: Cohen Neil Harris sold 2,304 shares ($6.52K)
- May 29, 2026: Mor George Adi bought 9,804 shares ($20.2K)
5%+ owners
- HBM Healthcare Investments (Cayman) Ltd.: 12.5% (Schedule 13D/A, filed Sep 9, 2026)
- Touchstone Global Investments Pty Ltd: 5.2% (Schedule 13G, filed Aug 13, 2026)